Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)

J Rheumatol. 2024 Jun 1;51(6):628-636. doi: 10.3899/jrheum.2023-0698.

Abstract

Objective: To identify the frequency and relative importance of symptoms experienced by adults with fibromyalgia (FM) and determine factors associated with a higher disease burden.

Methods: We conducted semistructured interviews with 15 participants with FM, collecting 1479 quotes regarding the symptomatic burden of FM. We then performed an international cross-sectional study involving 1085 participants with FM to determine the prevalence and relative importance (scale 0-4) of 149 symptoms representing 14 symptomatic themes. We performed subgroup analysis to determine how age, sex, disease duration, medication use, employment status, change in employment status, missing work due to FM, and ability level are related to symptomatic theme prevalence.

Results: The symptomatic themes with the highest prevalence in FM were pain (99.8%), muscle tenderness (99.8%), and fatigue (99.3%). The symptomatic themes that had the greatest effect on patients' lives were related to fatigue (2.88), pain (2.85), muscle tenderness (2.79), and impaired sleep and daytime sleepiness (2.70). Symptomatic theme prevalence was most strongly associated with the modified Rankin Scale level of disability, disability status, and change in employment status (on disability vs not on disability).

Conclusion: Participants with FM identify a variety of symptoms that significantly affect their daily lives. Many of these symptoms, such as fatigue, sleep disturbance, and activity limitation, are life-altering and not related to traditional diagnostic criteria. Symptom prevalence in this population varies across subgroups based on demographic categories and disability status.

Keywords: PRISM; disease burden; fibromyalgia; patient-reported outcomes.

MeSH terms

  • Adult
  • Aged
  • Cost of Illness
  • Cross-Sectional Studies
  • Disability Evaluation
  • Employment
  • Fatigue* / epidemiology
  • Female
  • Fibromyalgia* / epidemiology
  • Fibromyalgia* / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Pain / epidemiology
  • Patient Reported Outcome Measures
  • Prevalence
  • Quality of Life
  • Severity of Illness Index